Hepatocellular Carcinoma Recurrence and Anesthesia

• Sponsor: Seoul National University Bundang Hospital (Other)
• Overall Status: Completed
• CT.gov ID: NCT02643173
• Collaborator: (none)
• Enrollment: 259
• Location: 1
• Duration (Months): 45
• Patients Per Site Per Month: 5.8

Study Details

Study Description

Brief Summary

The investigators will verify the prognosis of hepatocellular carcinoma (HCC) according to the main anesthetic agents used for the general anesthesia.

Condition or Disease	Intervention/Treatment	Phase
Hepatocellular Carcinoma	Other: Volatile anesthetics; Other: Intravenous anesthetics

Study Design

• Study Type: Observational
• Actual Enrollment: 259 participants
• Observational Model: Cohort
• Time Perspective: Retrospective
• Study Start Date: Sep 1, 2015
• Actual Primary Completion Date: Jun 1, 2019
• Actual Study Completion Date: Jun 1, 2019

Arms and Interventions

Arm	Intervention/Treatment
Volatile The investigators retrospectively reviewed and analyzed the electrical medical records of patients who underwent surgery for HCC under the general anesthesia using volatile anesthetics as maintenance agents.	Other: Volatile anesthetics
Intravenous The investigators retrospectively reviewed and analyzed the electrical medical records of patients who underwent surgery for HCC under the general anesthesia using intravenous anesthetics as maintenance agents.	Other: Intravenous anesthetics

Outcome Measures

Primary Outcome Measures

1. Recurrence of HCC [Postoperative 2 year]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 20 Years to 100 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Patients undergoing surgery due to the HCC.

Exclusion Criteria:

• Patients undergoing re-operation due to the HCC.

• Patients presenting distant metastasis.

• Patients undergoing liver transplantation surgery.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Seoul National University Bundang Hospital	Seongnam	Gyeonggi	Korea, Republic of	463-707

Sponsors and Collaborators

• Seoul National University Bundang Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Hyo-Seok Na, Dr, Seoul National University Bundang Hospital
• ClinicalTrials.gov Identifier: NCT02643173
• Other Study ID Numbers: HCC recurrence
• First Posted: Dec 31, 2015
• Last Update Posted: Nov 22, 2019
• Last Verified: Nov 1, 2019

• Additional relevant MeSH terms: Carcinoma; Carcinoma, Hepatocellular; Anesthetics; Anesthetics, Intravenous

Study Results

No Results Posted as of Nov 22, 2019